Related Experiment Video
Updated: Mar 25, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
1.0K
[Colorectal cancer recurrence]
Sissel Ravn1, Kåre Andersson Gotschalck2, Jesper Nors3
1Mave- og Tarmkirurgisk Afdeling, Aalborg Universitetshospital.
Ugeskrift for Laeger
|March 24, 2026
Summary
Recurrent colorectal cancer (CRC) affects 16% of patients post-surgery, leading to high mortality. Early detection and improved treatments are crucial for better patient outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Research
Background:
- Recurrent colorectal cancer (CRC) impacts approximately 16% of patients within five years following curative surgery.
- High mortality rates are associated with CRC recurrence, posing a significant clinical challenge.
- Early tumor dissemination and the phenomenon of tumor dormancy complicate timely detection of recurrent disease.
Purpose of the Study:
- To review the current understanding of colorectal cancer recurrence patterns and challenges.
- To evaluate the effectiveness of current follow-up strategies for early detection.
- To explore treatment options and identify areas for future research in managing recurrent CRC.
Main Methods:
- Systematic literature review of studies on colorectal cancer recurrence.
- Analysis of data on recurrence rates, sites, detection methods, and treatment outcomes.
- Synthesis of findings to identify gaps in knowledge and clinical practice.
Main Results:
- The liver, lungs, and peritoneum are the most common sites for CRC recurrence.
- Current follow-up protocols aim for early detection, but their survival benefits remain uncertain.
- Approximately 50% of patients with recurrent CRC are candidates for curative treatment, including surgery or chemotherapy.
Conclusions:
- Effective strategies for early detection of recurrent colorectal cancer are needed.
- Further research is essential to improve treatment efficacy and long-term survival for patients with recurrent CRC.
- Addressing tumor dormancy and early dissemination is critical for improving outcomes in recurrent colorectal cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Treatment Resistent Cancers
1.5K
1.5K

